Search
for
Sort by
Research 571–600 of 1000+
- JAK inhibitors in dermatology: The promise of a new drug class
- Reversal of Alopecia Areata Following Treatment With the JAK1/2 Inhibitor Baricitinib
- A Comprehensive Literature Review of JAK Inhibitors in Treatment of Alopecia Areata
- A Review on the Use and Effectiveness of JAK Inhibitor in the Management of Lichen Planopilaris
- Topical 2% tofacitinib for children with alopecia areata, alopecia totalis, and alopecia universalis
- Alopecia Areata: Case report and review of pathophysiology and treatment with Jak inhibitors
- 3-Deoxysappanchalcone Promotes Proliferation of Human Hair Follicle Dermal Papilla Cells and Hair Growth in C57BL/6 Mice by Modulating WNT/β-Catenin and STAT Signaling
- Ageratum houstonianum Extract and Agerarin Promote Hair Growth via MAPK/AP-1 Axis-Dependent Upregulation of SCUBE3 in Human Dermal Papilla Cells
- The evaluation of JAK inhibitors on effect and safety in alopecia areata: a systematic review and meta-analysis of 2018 patients
- Monoclonal Antibody Against Prolactin Receptor: A Randomized Placebo-Controlled Study Evaluating Safety, Tolerability, and Pharmacokinetics of Repeated Subcutaneous Administrations in Postmenopausal Women
- Efficacy and safety of tofacitinib in patients with alopecia areata
- Two Mechanisms Regulate Keratin K15 Expression In Keratinocytes: Role of PKC/AP-1 and FOXM1 Mediated Signalling
- A Case Study of Stress-Induced Alopecia Areata Treated with Hominis Placenta Pharmacopunture
- Association of JAK 1 and JAK 2 gene polymorphism with alopecia areata risk: a case–control genetic study
- Discovery of a novel and highly selective JAK3 inhibitor as a potent hair growth promoter
- Theoretical investigation on the construction of hair follicle membranes and the transdermal drug delivery mechanisms of JAK inhibitors via distinct pathways
- Table 1_A decade of hair-loss clinical trials: a registry-based analysis of studies registered on ClinicalTrials.gov.docx
- Realising the therapeutic potential of neuroactive steroid modulators of the GABAA receptor
- 1,314
- Hair disorders in patients with cancer
- Epigenetic regulation in adult stem cells and cancers
- Comparison of the Treatment Outcome of Oral Tofacitinib with Other Conventional Therapies in Refractory Alopecia Totalis and Universalis: A Retrospective Study
- Diagnosis and management of hair loss in children
- How Long to Treat to Achieve Desired Treatment Outcomes with Baricitinib 4 mg in Severe Alopecia Areata: Evidence-based Approach
- 448 Challenges of securing insurance approval for oral tofacitinib treatment of alopecia areata: A multi-institutional retrospective review
- FRI0157 OBSERVATIONAL STUDY OF HAIR FALL IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH LOW DOSE METHOTREXATE COMPARED TO HEALTHY CONTROLS
- 1312 Nrf2 activation enhances the healing of cutaneous wounds through the activation of hair follicle stem cells
- Strategies to enhance epithelial–mesenchymal interactions for human hair follicle bioengineering
- Air pollution and skin diseases: Adverse effects of airborne particulate matter on various skin diseases
- Differences in activation of β-catenin in outer root sheath cells between the type of JAK inhibitor: An alternative mechanism promoting hair growth by JAK inhibitors in alopecia areata